BTIG Reiterates Buy Rating on Ascentage Pharma Group (AAPG)

April 13, 2026 6:06 AM EDT Send to a Friend
BTIG analyst Jeet Mukherjee reiterated a Buy rating and $48.00 price target on Ascentage Pharma Group (NASDAQ: AAPG).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login